New cancer drug enters human testing for patients out of options
Disease control
Recruiting now
This is the first study in humans testing an experimental drug called AWT020 for people with advanced cancer that has spread and no longer responds to standard treatments. The main goals are to find a safe dose and see how the drug behaves in the body. About 60 participants will …
Phase: PHASE1 • Sponsor: Anwita Biosciences • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC